{{Rsnum
|rsid=9349417
|Chromosome=6
|Orientation=plus
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene=CD2AP
|position=47612921
|Gene_s=CD2AP
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 52.2 | 39.8 | 8.0
| HCB | 76.5 | 22.1 | 1.5
| JPT | 78.8 | 18.6 | 2.7
| YRI | 52.7 | 41.8 | 5.5
| ASW | 49.1 | 49.1 | 1.8
| CHB | 76.5 | 22.1 | 1.5
| CHD | 75.2 | 23.9 | 0.9
| GIH | 53.5 | 41.6 | 5.0
| LWK | 47.3 | 42.7 | 10.0
| MEX | 56.9 | 39.7 | 3.4
| MKK | 52.6 | 38.5 | 9.0
| TSI | 55.9 | 36.3 | 7.8
| HapMapRevision=28
}}{{PMID Auto
|PMID=23681557
|Title=CD2AP is associated with end-stage renal disease in patients with type 1 diabetes
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}